Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Posts 12 Percent Revenue Gain for Q3

NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market yesterday a 12 percent increase year over year for its third quarter.

The San Diego-based life sciences informatics firm reported GAAP revenues of $40.5 million for the three months ended Sept. 30, compared to $36.3 million for the third quarter of 2011.

Its non-GAAP revenue, which includes a deferred revenue fair value adjustment related to its merger with Symyx and acquisitions of Contur and VelQuest, was $43.4 million versus 38 million, a 14 percent increase.

Accelrys posted net income of $601,000, or $.01 per share, compared to a net loss of $2.2 million, or $.04 per share, for Q3 2011. On a non-GAAP basis, its EPS was $.11 versus $.10 for the prior year. The third quarter of 2011 had included $2.3 million in business consolidation, transaction, and restructuring costs, compared to $658,000 of such costs for the third quarter of 2012.

Its product development costs increased 38 percent to $490,000 from $356,000, and its SG&A expenses rose 18 percent to $1.3 million from $1.1 million.

Accelrys finished the quarter with $160.1 million in cash, cash equivalents, and marketable securities.

The firm expects to report non-GAAP revenue of between $169 million and $171 million, and non-GAAP earnings per share of between $.32 and $.33 for the full year ending Dec. 31.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.